Cancer Immunology

A cancer vaccine is an immunization that either treats existing tumor or averts improvement of a malignancy. Antibodies that regard existing malignancy are known as restorative tumor vaccines. One way to deal with disease immunization is to separate proteins from growth cells and vaccinate patients against those proteins as antigens, in the expectation of empowering the immune system to execute the cancer cells. Another approach is to produce a resistant reaction in situ in the patient utilizing oncolytic infections.

  • Tumor vaccines
  • Oncolytic infections
  • Resistant reactions in situ
  • Proteins as antigens

Related Conference of Cancer Immunology

December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Paris, France
December 12-13, 2024

44th Euro Congress on Cancer Science & Therapy

Rome, Italy
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Cancer Immunology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in